CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Dextrose Monohydrate 70% Injection
FDA source answer
FDA currently lists this ingredient in shortage.
FDA source statuses: Current. First FDA posting: 2024-10-11. Latest FDA row update: 2026-10-02.
FDA lists 4 package records, with companies: B. Braun Medical Inc., Baxter Healthcare, Baxter Healthcare Corporation, ICU Medical Inc., Otsuka ICU Medical LLC. Package NDCs: 0264-7387-50, 0338-0719-06, 0990-7120-07, 0990-7918-19.
FDA shortage reason: Other
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| B. Braun Medical Inc. | 0264-7387-50 | Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0264-7387-50) | Available | 2026-09-22 |
| Baxter Healthcare | 0338-0719-06 | Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0338-0719-06) | Limited Availability | 2026-10-02 |
| Otsuka ICU Medical LLC | 0990-7120-07 | DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7120-07) | Available | 2026-10-01 |
| Otsuka ICU Medical LLC | 0990-7918-19 | DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7918-19) | Available | 2026-10-01 |
Source facts
Grouped generic ingredient: Dextrose Monohydrate 70% Injection · 4 package records
Therapeutic categories: Endocrinology/Metabolism, Gastroenterology, Other, Pediatric
Dosage forms: Injection
Routes: INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.